Cargando…

Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment

Detalles Bibliográficos
Autores principales: Badal, Shawn S., Danesh, Farhad R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876692/
https://www.ncbi.nlm.nih.gov/pubmed/26294427
http://dx.doi.org/10.2337/db15-0738
_version_ 1782433278338269184
author Badal, Shawn S.
Danesh, Farhad R.
author_facet Badal, Shawn S.
Danesh, Farhad R.
author_sort Badal, Shawn S.
collection PubMed
description
format Online
Article
Text
id pubmed-4876692
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-48766922016-09-01 Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment Badal, Shawn S. Danesh, Farhad R. Diabetes Commentaries American Diabetes Association 2015-09 2015-08-13 /pmc/articles/PMC4876692/ /pubmed/26294427 http://dx.doi.org/10.2337/db15-0738 Text en © 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
spellingShingle Commentaries
Badal, Shawn S.
Danesh, Farhad R.
Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
title Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
title_full Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
title_fullStr Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
title_full_unstemmed Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
title_short Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
title_sort diabetic nephropathy: emerging biomarkers for risk assessment
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876692/
https://www.ncbi.nlm.nih.gov/pubmed/26294427
http://dx.doi.org/10.2337/db15-0738
work_keys_str_mv AT badalshawns diabeticnephropathyemergingbiomarkersforriskassessment
AT daneshfarhadr diabeticnephropathyemergingbiomarkersforriskassessment